Gastric Cancer Registry
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0002284
- Lead Sponsor
- Kyungpook National University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 18000
Inclusion Criteria
All patients aged more than 18 years who were diagnosed primary gastric adenocarcinoma (6000 patients)
Control participants aged more than 40 years without previous history of gastric cancer & who agreed on participation (12000 persons)
Exclusion Criteria
Patients or Person who denied to participate
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prediction of risk factors for gastric cancer and definition of optimal endoscopic screening interval
- Secondary Outcome Measures
Name Time Method The diagnostic validity of serum biomarker (serum pepsinogen and TFF3) for detection of gastric cancer;Analysis of current treatment patterns of gastric cancer and outcomes;To compare the prognosis and quality of life after early gastric cancer between endoscopic treatment group and surgery group;To evaluate the incidence of gastric cancer development in control group;To evaluate the incidence of metachronous gastric neoplasm after endoscopic treatment or surgery ;To evaluate the characteristics of gastric cancer patients who have family history of gastric cancer ;Stage, treatment and prognosis of gastric cancer according to molecular classification;Stage, treatment and prognosis of gastric cancer according to endoscopic screening interval;Reservation of frozen serum for novel gastric cancer serologic marker analysis